相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Activators of alpha synuclein expression identified by reporter cell line-based high throughput drug screen
Fabian Stahl et al.
SCIENTIFIC REPORTS (2021)
Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30
Yasmin Fardghassemi et al.
NEUROTHERAPEUTICS (2021)
Hydrophilic or Lipophilic Statins?
Elisenda Climent et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein
Naila S. Ashraf et al.
NEUROBIOLOGY OF DISEASE (2020)
CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing
Kornel Labun et al.
NUCLEIC ACIDS RESEARCH (2019)
Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia
Clevio Nobrega et al.
ACTA NEUROPATHOLOGICA (2019)
Statins and the Brain: More than Lipid Lowering Agents?
Anna Fracassi et al.
CURRENT NEUROPHARMACOLOGY (2019)
Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
Lodewijk J. A. Toonen et al.
MOLECULAR NEURODEGENERATION (2018)
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Shi-You Jiang et al.
NATURE COMMUNICATIONS (2018)
Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3
Maria do Carmo Costa et al.
BRAIN (2016)
JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles
Anthony Mathelier et al.
NUCLEIC ACIDS RESEARCH (2014)
ENCODE Data in the UCSC Genome Browser: year 5 update
Kate R. Rosenbloom et al.
NUCLEIC ACIDS RESEARCH (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Large-Scale Screen for Modifiers of Ataxin-3-Derived Polyglutamine-Induced Toxicity in Drosophila
Hannes Vossfeldt et al.
PLOS ONE (2012)
Toward understanding Machado-Joseph disease
Maria do Carmo Costa et al.
PROGRESS IN NEUROBIOLOGY (2012)
Statins as Neuroprotectants: A Comparative In Vitro Study of Lipophilicity, Blood-Brain-Barrier Penetration, Lowering of Brain Cholesterol, and Decrease of Neuron Cell Death
Saleta Sierra et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease
Philipp Koch et al.
NATURE (2011)
MotifMap: a human genome-wide map of candidate regulatory motif sites
Xiaohui Xie et al.
BIOINFORMATICS (2009)
Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase
Russell A. DeBose-Boyd
CELL RESEARCH (2008)
Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates
Xiaoyan Zhong et al.
HUMAN MOLECULAR GENETICS (2006)
An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis
A Boeddrich et al.
EMBO JOURNAL (2006)
Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin
KM Thelen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex
LN Johnson-Anuna et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Selective coactivator interactions in gene activation by SREBP-1a and-1c
JI Toth et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes
JD Horton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The human MJD gene:: genomic structure and functional characterization of the promoter region
I Schmitt et al.
GENE (2003)
The human genome browser at UCSC
WJ Kent et al.
GENOME RESEARCH (2002)